Received Jul 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | DN273 | IM / RA |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | 1965035 | IM / LA |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | N/A | Y009956 | IM / RA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | CX4HL | IM / RA |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 2 | Y009956 | IM / LA |
Prevnar 20 was administered, when the client should have received Meningococcal ACWY vaccines. Client has not experienced any adverse reactions, events, treatments or outcomes.
None
None
None
None